PRZIX
Price
$34.47
Change
+$0.44 (+1.29%)
Updated
Jan 30 closing price
Net Assets
4.94B
VEMAX
Price
$37.12
Change
+$0.41 (+1.12%)
Updated
Jan 30 closing price
Net Assets
108.96B
Ad is loading...

PRZIX vs VEMAX

Header iconPRZIX vs VEMAX Comparison
Open Charts PRZIX vs VEMAXBanner chart's image
T. Rowe Price Emerging Markets Stock I
Price$34.47
Change+$0.44 (+1.29%)
VolumeN/A
Net Assets4.94B
Vanguard Emerging Mkts Stock Idx Adm
Price$37.12
Change+$0.41 (+1.12%)
VolumeN/A
Net Assets108.96B
PRZIX vs VEMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PRZIX vs. VEMAX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRZIX is a Hold and VEMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 109B vs. PRZIX (4.94B). VEMAX pays higher dividends than PRZIX: VEMAX (3.43) vs PRZIX (1.64). PRZIX was incepted earlier than VEMAX: PRZIX (9 years) vs VEMAX (19 years). PRZIX is a more actively managed with annual turnover of: 47.60 vs. VEMAX (5.00). VEMAX has a lower initial minimum investment than PRZIX: VEMAX (3000) vs PRZIX (500000). VEMAX annual gain was more profitable for investors over the last year : 13.85 vs. PRZIX (6.23). VEMAX return over 5 years is better than : 15.47 vs. PRZIX (-20.09).
PRZIXVEMAXPRZIX / VEMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years19 years-
Gain YTD1.681-0.163-1,030%
Front LoadN/AN/A-
Min. Initial Investment500000300016,667%
Min. Initial Investment IRAN/AN/A-
Net Assets4.94B109B5%
Annual Yield % from dividends1.643.4348%
Returns for 1 year6.2313.8545%
Returns for 3 years-21.89-4.03543%
Returns for 5 years-20.0915.47-130%
Returns for 10 yearsN/A29.03-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNVS3.660.16
+4.57%
Cineverse Corp
SABR3.390.08
+2.42%
Sabre Corp
PTCT46.150.93
+2.06%
PTC Therapeutics
OPRX5.710.05
+0.88%
OptimizeRx Corp
K81.940.17
+0.21%
Kellanova